Antitumoral Action of Resveratrol Through Adenosinergic Signaling in C6 Glioma Cells

The Plant-Derived Compound Resveratrol in Brain Cancer: A Review

(2020) Terezia Kiskova et al.   Biomolecules

Elevated intracellular cAMP concentration mediates growth suppression in glioma cells

(2020) Dewi Safitri et al.   BIOCHEMICAL PHARMACOLOGY

P2X7 in Cancer: From Molecular Mechanisms to Therapeutics

(2020) Romain Lara et al.   Frontiers in Pharmacology

Extracellular ATP: A Feasible Target for Cancer Therapy

(2020) Valentina Vultaggio-Poma et al.   Cells

History of ectonucleotidases and their role in purinergic signaling

(2020) Herbert Zimmermann   BIOCHEMICAL PHARMACOLOGY

The antioxidant resveratrol acts as a non-selective adenosine receptor agonist

(2019) A. Sánchez-Melgar et al.   FREE RADICAL BIOLOGY AND MEDICINE

CD73 Promotes Glioblastoma Pathogenesis and Enhances Its Chemoresistance via A2B Adenosine Receptor Signaling

(2019) Angela Yan et al.   JOURNAL OF NEUROSCIENCE

Adenosine receptors as novel targets for the treatment of various cancers

(2019) Bapi Gorain et al.   CURRENT PHARMACEUTICAL DESIGN

Modulation of Adenosine Receptors and Antioxidative Effect of Beer Extracts in in Vitro Models

(2019) Patricia Alonso-Andrés et al.   Nutrients

Purine-related metabolites and their converting enzymes are altered in frontal, parietal and temporal cortex at early stages of Alzheimer's disease pathology

(2018) Patricia Alonso-Andrés et al.   BRAIN PATHOLOGY

WHO 2016 Classification of gliomas

(2018) P. Wesseling et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Pharmacology of Adenosine Receptors: The State of the Art

(2018) Pier Andrea Borea et al.   PHYSIOLOGICAL REVIEWS

Resveratrol Modulates and Reverses the Age-Related Effect on Adenosine-Mediated Signalling in SAMP8 Mice

(2018) A. Sánchez-Melgar et al.   MOLECULAR NEUROBIOLOGY

The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets

(2017) Bertrand Allard et al.   IMMUNOLOGICAL REVIEWS

Targeting A2 adenosine receptors in cancer

(2017) David Allard et al.   IMMUNOLOGY AND CELL BIOLOGY

Extracellular 5′-nucleotidase (CD73) promotes human breast cancer cells growth through AKT/GSK-3β/β-catenin/cyclinD1 signaling pathway

(2017) Jiangang Yu et al.   INTERNATIONAL JOURNAL OF CANCER

The Role of Resveratrol in Cancer Therapy

(2017) Jeong-Hyeon Ko et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer

(2017) Mohammad H. Kazemi et al.   JOURNAL OF CELLULAR PHYSIOLOGY

CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer

(2017) Jianjie Zhu et al.   Molecular Cancer

AMPK: guardian of metabolism and mitochondrial homeostasis

(2017) Sébastien Herzig et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

The effect of resveratrol, its naturally occurring derivatives and tannic acid on the induction of cell cycle arrest and apoptosis in rat C6 and human T98G glioma cell lines

(2017) Małgorzata Zielińska-Przyjemska et al.   TOXICOLOGY IN VITRO

Resveratrol Regulates Colorectal Cancer Cell Invasion by Modulation of Focal Adhesion Molecules

(2017) Constanze Buhrmann et al.   Nutrients

CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer

(2017) Jieyao Li et al.   OncoImmunology

Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses

(2016) Arabella Young et al.   CANCER CELL

Role of adenosine A2b receptor overexpression in tumor progression

(2016) Cesar Sepúlveda et al.   LIFE SCIENCES

Extracellular purines, purinergic receptors and tumor growth

(2016) F Di Virgilio et al.   ONCOGENE

Resveratrol inhibits cell cycle progression by targeting Aurora kinase A and Polo-like kinase 1 in breast cancer cells

(2016) RUBICELI MEDINA-AGUILAR et al.   ONCOLOGY REPORTS

CD73 as a novel marker for poor prognosis of oral squamous cell carcinoma

(2016) ZHEN-HU REN et al.   Oncology Letters

CD73 is associated with poor prognosis in HNSCC

(2016) Zhen-Hu Ren et al.   Oncotarget

A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment

(2016) Akio Ohta   Frontiers in Immunology

The molecular targets of resveratrol

(2015) Sameer S. Kulkarni et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer

(2015) Martin Turcotte et al.   CANCER RESEARCH

Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways

(2015) GUANGXIU WANG et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Hyperthermia-induced seizures alter adenosine A1and A2Areceptors and 5′-nucleotidase activity in rat cerebral cortex

(2015) David Agustín León-Navarro et al.   JOURNAL OF NEUROCHEMISTRY

Adenosine Receptor 2A Blockade Increases the Efficacy of Anti–PD-1 through Enhanced Antitumor T-cell Responses

(2015) Paul A. Beavis et al.   Cancer Immunology Research

Differential AMPK phosphorylation by glucagon and metformin regulates insulin signaling in human hepatic cells

(2014) Darius Kang Lie Aw et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Resveratrol and cancer: focus on in vivo evidence

(2014) Lindsay G Carter et al.   ENDOCRINE-RELATED CANCER

Adenosine uptake is the major effector of extracellular ATP toxicity in human cervical cancer cells

(2014) Paola de Andrade Mello et al.   MOLECULAR BIOLOGY OF THE CELL

Resveratrol inhibits the proliferation of human melanoma cells by inducing G1/S cell cycle arrest and apoptosis

(2014) ZHIYUAN WU et al.   Molecular Medicine Reports

Resveratrol inhibits proliferation in human colorectal carcinoma cells by inducing G1/S-phase cell cycle arrest and apoptosis through caspase/cyclin-CDK pathways

(2014) BIN LIU et al.   Molecular Medicine Reports

Extracellular Adenosine-Mediated Modulation of Regulatory T Cells

(2014) Akio Ohta et al.   Frontiers in Immunology

Antagonism of adenosine A2A receptor expressed by lung adenocarcinoma tumor cells and cancer associated fibroblasts inhibits their growth

(2013) Melanie Mediavilla-Varela et al.   CANCER BIOLOGY & THERAPY

CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer

(2013) S. Loi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

CD73-Deficient Mice Are Resistant to Carcinogenesis

(2012) J. Stagg et al.   CANCER RESEARCH

CD73-Generated Adenosine: Orchestrating the Tumor-Stroma Interplay to Promote Cancer Growth

(2012) Bertrand Allard et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

CD73 promotes tumor growth and metastasis

(2012) Bin Zhang   OncoImmunology

CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis

(2011) J. Stagg et al.   CANCER RESEARCH

International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors--An Update

(2011) B. B. Fredholm et al.   PHARMACOLOGICAL REVIEWS

CD73-Dependent Regulation of Interferon AlphaA and Interleukin-10 in the Inflamed Mucosa

(2011) Ilya Sotnikov et al.   TheScientificWorldJOURNAL

Adenosine receptors and cancer

(2010) Stefania Gessi et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis

(2010) J. Stagg et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

PKA phosphorylates and inactivates AMPKα to promote efficient lipolysis

(2009) Nabil Djouder et al.   EMBO JOURNAL

Modulation of adenosine A1 and A2A receptors in C6 glioma cells during hypoxia: involvement of endogenous adenosine

(2008) Carlos A. Castillo et al.   JOURNAL OF NEUROCHEMISTRY

The role of ecto-5′-nucleotidase/CD73 in glioma cell line proliferation

(2008) Luci Bavaresco et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY